Ferreira M. M. C., Kiralj, R., “Quantitative relationships between b-lactam molecular properties and b-lactam/AcrAB-TolC complex geometry as determinants of MDR efflux”. São Pedro, SP, 20-23/11/2005: XIII Simpósio Brasileiro de Química Teórica (XIII SBQT) [13th Brazilian Symposium of Theoretical Chemistry], Livro de Resumos [Book of Abstracts], 198. Poster 198.
198
Quantitative relationships
between b-lactam
molecular properties and b-lactam/AcrAB-TolC
complex
geometry as determinants
of MDR efflux
Márcia M. C. Ferreira (PQ), Rudolf Kiralj (PQ). rudolf@iqm.unicamp.br
Instituto de Química, Universidade Estadual de Campinas, 13083-970 Campinas, SP, Brazil
Palavras-Chaves: mutidrug resistance, semi-empirical methods, molecular descriptors
INTRODUCTION
Multidrug resistance
(MDR) of microbes and parasites as well as
of cancer cells to currently used drugs
is becoming one of the major
problems in combating infectious and parasitic diseases and cancer, respectively.
Among major
mechanisms of multidrug resistance in cellular
microbes and cancer cells are efflux pumps,
macromolecular systems
that extrude drugs and a large variety of structurally dissimilar
substances from cell
into the outside medium.
Bacterial MDR efflux pump AcrAB-TolC exists in E. coli, S.
typhimurium and several
other Gram-negative
bacteria as their major efflux system,
being effective against b-lactams
and other
antibiotics, organic
dyes, detergents and many xenobiotics.
It is a proton-motive device that connects the
inner and outer cell membranes.
The pump consists of the tube-like TolC trimer, the jellyfish-like
AcrB trimer,
and the
AcrA oligomer. AcrB is
responsible for attraction of
substrates that are coming
from
periplasm/cytoplasm,
their accumulation in its central cavity, and their expulsion
through its channel and the
TolC channel.
Proton influx induces a series of allosteric changes in the pump and its
components, enabling
opening of the channels.
Substrates in the central cavity must be placed and oriented
in appropriate way to
be extruded.
METHODS
In this work,
the relationships between drug molecular properties
and drug-receptor interaction geometry
have been
studied at quantitative level.
Experimental 3D structures of
four AcrB-drug complexes
(dequalinium,
ethidium, ciprofloxacin and ethidium
[1]) were used. The drug-protein
geometry and
stereoelectronic molecular
properties of these drugs and of 16 b-lactams
enabled prediction of positional and
orientational parameters
of these b-lactams
placed inside AcrB [2] via linear
regression equations with the
best variable selection.
Prior to this analysis, the geometry of all drugs was
modeled according to available
experimental and modeled
structural data, and then optimized at PM3 semi-empirical
level after Montecarlo
conformational search,
taking into account the ionic state of the
drugs at neutral pH and preserving the
bioactive conformation of
the four drugs as in the complexes with AcrB.
Programs Titan and MOPAC 6.0
were used for all quantum-chemical
computations. Crystallographc C3
symmetry of AcrB (space group R32)
facilitated definition of
AcrB crucial axes and points, as well as drug-receptor
geometry parameters (drug-
central cavity
distance and angle parameters). After
predicting the drug-AcrB geometry parameters
for
b-lactams,
all drugs were superimposed in the
common coordinate system of the uncomplexed
AcrB.
Molecular graphics was performed
by using Titan, PLATON and WebLab Viewer
programs. Experimental
geometries of AcrB (complexed
and uncomplexed) were from E. coli.
RESULTS AND DISCUSSION
Molecular descriptors of
the four drugs (dequalinium, ethidium, ciprofloxacin and ethidium)
that quantitatively
correlated with
these parameters (correlation coefficients above 0.82)
were principal moments of inertia,
molecular box parameters,
dipole moment and its components, polarizability an hyperpolarizabilities.
These
molecular properties
showed similar behavior as those for b-lactams
in terms of intercorrelations and
correlations with the efflux
activity of AcrAB-TolC pump in three strains of S. typhimurium
(negative logarithm
of Minimal Inhibitory Concentration)
[3]. The new modeled AcrB/b-lactam
complexes show that drugs interact
with the vestibule by
electrostatic interactions, before binding
in the central cavity and turning with their
positive ends toward
the opening of the AcrB channel. These
results are consistent with known pump-
mediated drug
efflux mechanism and our previous quantitative
structure-activity studies [4]. Elongated
cylinder-like b-lactam
antibiotics with lipophylic side chains, significantly negative
Y component of the dipole
moment and low
hydrogen bonding capacity seem to be good substrates
of AcrAB-TolC MDR efflux pump
CONCLUSIONS
Stereoelectronic molecular
properties of b-lactams
and structurally dissimilar compounds are quantitatively
related to AcB-drug complex
geometry. This explains the crucial point of the drug efflux, the
orientation of an
amphiphilic drug with respect
to the inner membrane and the AcrAB-TolC pump in a Gram-negative
bacteria.
ACKNOWLEDGEMENT: FAPESP
LITERATURE
[1] E. W. Yu et al.,
Science300
(2003) 976-980.
[2] M. M. C. Ferreira, R.
Kiralj, J. Mol. Graph. Mod., submitted.
[3] H. Nikaido, M. Basina,
V. Nguyen, J. Bacteriol. 180 (1998) 4886-4692.
[4] M. M. C. Ferreira, R.
Kiralj, J. Chemometr. 18 (2004) 242-252.